Cargando…
Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex
The muscarinic-cholinergic system is involved in the pathophysiology of bipolar disorder (BD), and contributes to attention and the top-down and bottom-up cognitive and affective mechanisms of emotional processing, functionally altered in BD. Emotion processing can be assessed by the ability to inhi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283431/ https://www.ncbi.nlm.nih.gov/pubmed/35046509 http://dx.doi.org/10.1038/s41386-022-01268-7 |
_version_ | 1784747310388871168 |
---|---|
author | Nabulsi, Leila Farrell, Jennifer McPhilemy, Genevieve Kilmartin, Liam Dauvermann, Maria R. Akudjedu, Theophilus N. Najt, Pablo Ambati, Srinath Martyn, Fiona M. McLoughlin, James Gill, Michael Meaney, James Morris, Derek Frodl, Thomas McDonald, Colm Hallahan, Brian Cannon, Dara M. |
author_facet | Nabulsi, Leila Farrell, Jennifer McPhilemy, Genevieve Kilmartin, Liam Dauvermann, Maria R. Akudjedu, Theophilus N. Najt, Pablo Ambati, Srinath Martyn, Fiona M. McLoughlin, James Gill, Michael Meaney, James Morris, Derek Frodl, Thomas McDonald, Colm Hallahan, Brian Cannon, Dara M. |
author_sort | Nabulsi, Leila |
collection | PubMed |
description | The muscarinic-cholinergic system is involved in the pathophysiology of bipolar disorder (BD), and contributes to attention and the top-down and bottom-up cognitive and affective mechanisms of emotional processing, functionally altered in BD. Emotion processing can be assessed by the ability to inhibit a response when the content of the image is emotional. Impaired regulatory capacity of cholinergic neurotransmission conferred by reduced M(2)-autoreceptor availability is hypothesized to play a role in elevated salience of negative emotional distractors in euthymic BD relative to individuals with no history of mood instability. Thirty-three euthymic BD type-I (DSM-V-TR) and 50 psychiatrically-healthy controls underwent functional magnetic resonance imaging (fMRI) and an emotion-inhibition paradigm before and after intravenous cholinergic challenge using the acetylcholinesterase inhibitor, physostigmine (1 mg), or placebo. Mood, accuracy, and reaction time on either recognizing or inhibiting a response associated with an image involving emotion and regional functional activation were examined for effects of cholinergic challenge physostigmine relative to placebo, prioritizing any interaction with the diagnostic group. Analyses revealed that (1) at baseline, impaired behavioral performance was associated with lower activation in the anterior cingulate cortex in BD relative to controls during emotion processing; (2) physostigmine (vs. placebo) affected behavioral performance during the inhibition of negative emotions, without altering mood, and increased activation in the posterior cingulate cortex in BD (vs. controls); (3) In BD, lower accuracy observed during emotion inhibition of negative emotions was remediated by physostigmine and was associated with cingulate cortex overactivation. Our findings implicate abnormal regulation of cholinergic neurotransmission in the cingulate cortices in BD, which may mediate exaggerated emotional salience processing, a core feature of BD. |
format | Online Article Text |
id | pubmed-9283431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-92834312022-07-16 Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex Nabulsi, Leila Farrell, Jennifer McPhilemy, Genevieve Kilmartin, Liam Dauvermann, Maria R. Akudjedu, Theophilus N. Najt, Pablo Ambati, Srinath Martyn, Fiona M. McLoughlin, James Gill, Michael Meaney, James Morris, Derek Frodl, Thomas McDonald, Colm Hallahan, Brian Cannon, Dara M. Neuropsychopharmacology Article The muscarinic-cholinergic system is involved in the pathophysiology of bipolar disorder (BD), and contributes to attention and the top-down and bottom-up cognitive and affective mechanisms of emotional processing, functionally altered in BD. Emotion processing can be assessed by the ability to inhibit a response when the content of the image is emotional. Impaired regulatory capacity of cholinergic neurotransmission conferred by reduced M(2)-autoreceptor availability is hypothesized to play a role in elevated salience of negative emotional distractors in euthymic BD relative to individuals with no history of mood instability. Thirty-three euthymic BD type-I (DSM-V-TR) and 50 psychiatrically-healthy controls underwent functional magnetic resonance imaging (fMRI) and an emotion-inhibition paradigm before and after intravenous cholinergic challenge using the acetylcholinesterase inhibitor, physostigmine (1 mg), or placebo. Mood, accuracy, and reaction time on either recognizing or inhibiting a response associated with an image involving emotion and regional functional activation were examined for effects of cholinergic challenge physostigmine relative to placebo, prioritizing any interaction with the diagnostic group. Analyses revealed that (1) at baseline, impaired behavioral performance was associated with lower activation in the anterior cingulate cortex in BD relative to controls during emotion processing; (2) physostigmine (vs. placebo) affected behavioral performance during the inhibition of negative emotions, without altering mood, and increased activation in the posterior cingulate cortex in BD (vs. controls); (3) In BD, lower accuracy observed during emotion inhibition of negative emotions was remediated by physostigmine and was associated with cingulate cortex overactivation. Our findings implicate abnormal regulation of cholinergic neurotransmission in the cingulate cortices in BD, which may mediate exaggerated emotional salience processing, a core feature of BD. Springer International Publishing 2022-01-19 2022-08 /pmc/articles/PMC9283431/ /pubmed/35046509 http://dx.doi.org/10.1038/s41386-022-01268-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Nabulsi, Leila Farrell, Jennifer McPhilemy, Genevieve Kilmartin, Liam Dauvermann, Maria R. Akudjedu, Theophilus N. Najt, Pablo Ambati, Srinath Martyn, Fiona M. McLoughlin, James Gill, Michael Meaney, James Morris, Derek Frodl, Thomas McDonald, Colm Hallahan, Brian Cannon, Dara M. Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title | Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title_full | Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title_fullStr | Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title_full_unstemmed | Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title_short | Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
title_sort | normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283431/ https://www.ncbi.nlm.nih.gov/pubmed/35046509 http://dx.doi.org/10.1038/s41386-022-01268-7 |
work_keys_str_mv | AT nabulsileila normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT farrelljennifer normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT mcphilemygenevieve normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT kilmartinliam normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT dauvermannmariar normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT akudjedutheophilusn normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT najtpablo normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT ambatisrinath normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT martynfionam normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT mcloughlinjames normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT gillmichael normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT meaneyjames normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT morrisderek normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT frodlthomas normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT mcdonaldcolm normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT hallahanbrian normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex AT cannondaram normalizationofimpairedemotioninhibitioninbipolardisordermediatedbycholinergicneurotransmissioninthecingulatecortex |